© 2001 by European Society of Cardiology
Copyright © 2001, European Society of Cardiology
Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications
Department of Internal Medicine II (Cardiology), Ulm University Medical Center, Robert-Koch-Strasse 8, 89081 Ulm, Germany
* Tel.: +49-731-5003-1158; fax: +49-731-5002-4533 johannes.waltenberger{at}medizin.uni-ulm.de
The formation of coronary collateral vessels is a compensatory mechanism secondary to repetitive or chronic myocardial ischemia. During the past three decades the functional and prognostic benefit of such collateral vessels has been established. There are large interindividual differences in the number and extent of collateral vessels that may be explained by differences in the anatomic situation or by differences in the individual capacity to develop functional collateral vessels. Diabetes mellitus has recently been identified as one of the first negative predictors of collateral vessel formation. Novel molecular approaches have helped to improve our understanding of the process of collateral vessel formation in recent years. Besides the process of true angiogenesis, i.e. the formation of new capillaries out of preexisting ones, the formation of a collateral circulation is largely based on the growth of preexisting arterioles (collateral vessels or anastomoses) named arteriogenesis. One important feature of arteriogenesis is the infiltration of monocytes into the growing collateral vessel. Our group shows that the ability of monocytes to migrate towards a gradient of VEGF-A is severely impaired in diabetic individuals, and this impaired response seems to be secondary to a signal transduction defect within the monocyte. In this review the pathophysiology of diabetes-related monocyte dysfunction and the potential role of VEGF-A in collateral vessel formation are discussed.
KEYWORDS Collateral circulation; Angiogenesis; Growth factors; Signal transduction; Diabetes
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Sarkar, K. Fox-Talbot, C. Steenbergen, M. Bosch-Marce, and G. L. Semenza Adenoviral transfer of HIF-1{alpha} enhances vascular responses to critical limb ischemia in diabetic mice PNAS, November 3, 2009; 106(44): 18769 - 18774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Simons Diabetic Monocyte and Vascular Endothelial Growth Factor Signaling Impairment Circulation, July 14, 2009; 120(2): 104 - 105. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Waltenberger Limits to Growth of Native Collateral Vessels: Just One Mouse CLIC Away From Unlimited Collateral Perfusion? Circ. Res., July 2, 2009; 105(1): 9 - 11. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Au, J. Tam, D. G. Duda, P.-C. Lin, L. L. Munn, D. Fukumura, and R. K. Jain Paradoxical Effects of PDGF-BB Overexpression in Endothelial Cells on Engineered Blood Vessels In Vivo Am. J. Pathol., July 1, 2009; 175(1): 294 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Al Mheid and A. A. Quyyumi Cell Therapy in Peripheral Arterial Disease Angiology, January 1, 2009; 59(6): 705 - 716. [Abstract] [PDF]
|
|
|
|
 |
|
 M. C. van Oostrom, O. van Oostrom, P. H. A. Quax, M. C. Verhaar, and I. E. Hoefer Insights into mechanisms behind arteriogenesis: what does the future hold? J. Leukoc. Biol., December 1, 2008; 84(6): 1379 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Gealekman, A. Burkart, M. Chouinard, S. M. Nicoloro, J. Straubhaar, and S. Corvera Enhanced angiogenesis in obesity and in response to PPAR{gamma} activators through adipocyte VEGF and ANGPTL4 production Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1056 - E1064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. de Resende, S. L. Amaral, C. Moreno, and A. S. Greene Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation Physiol Genomics, October 8, 2008; 33(1): 33 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-X. Chen and A. Stinnett Disruption of Ang-1/Tie-2 Signaling Contributes to the Impaired Myocardial Vascular Maturation and Angiogenesis in Type II Diabetic Mice Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1606 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chu, K.-H. Jung, S.-T. Lee, H.-K. Park, D.-I. Sinn, J.-M. Kim, D.-H. Kim, J.-H. Kim, S.-J. Kim, E.-C. Song, et al. Circulating Endothelial Progenitor Cells as a New Marker of Endothelial Dysfunction or Repair in Acute Stroke * Supplemental Methods Stroke, May 1, 2008; 39(5): 1441 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Luo, Y. Soesanto, and D. A. McClain Protein Modification by O-Linked GlcNAc Reduces Angiogenesis by Inhibiting Akt Activity in Endothelial Cells Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 651 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Fadini, S. Sartore, C. Agostini, and A. Avogaro Significance of Endothelial Progenitor Cells in Subjects With Diabetes Diabetes Care, May 1, 2007; 30(5): 1305 - 1313. [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Hopkins, N. Ouchi, R. Shibata, and K. Walsh Adiponectin actions in the cardiovascular system Cardiovasc Res, April 1, 2007; 74(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, S. Hazarika, D. Xie, A. M. Pippen, C. D. Kontos, and B. H. Annex In Mice With Type 2 Diabetes, a Vascular Endothelial Growth Factor (VEGF)-Activating Transcription Factor Modulates VEGF Signaling and Induces Therapeutic Angiogenesis After Hindlimb Ischemia Diabetes, March 1, 2007; 56(3): 656 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Shantsila, T. Watson, and G. Y.H. Lip Endothelial Progenitor Cells in Cardiovascular Disorders J. Am. Coll. Cardiol., February 20, 2007; 49(7): 741 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Stadler, J. Eggermann, S. Voo, A. Kranz, and J. Waltenberger Smoking-Induced Monocyte Dysfunction Is Reversed by Vitamin C Supplementation In Vivo Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 120 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Chittenden, J. A. Sherman, F. Xiong, A. E. Hall, A. A. Lanahan, J. M. Taylor, H. Duan, J. D. Pearlman, J. H. Moore, S. M. Schwartz, et al. Transcriptional Profiling in Coronary Artery Disease: Indications for Novel Markers of Coronary Collateralization Circulation, October 24, 2006; 114(17): 1811 - 1820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Fadini, S. Sartore, M. Albiero, I. Baesso, E. Murphy, M. Menegolo, F. Grego, S. Vigili de Kreutzenberg, A. Tiengo, C. Agostini, et al. Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2140 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shoji, H. Koyama, T. Morioka, S. Tanaka, A. Kizu, K. Motoyama, K. Mori, S. Fukumoto, A. Shioi, N. Shimogaito, et al. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes, August 1, 2006; 55(8): 2245 - 2255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-S. Li, A. Furutani, M. Takahashi, M. Ohshima, S.-L. Qin, T. Kobayashi, H. Ito, and K. Hamano Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1362 - H1369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Gilbert, K. Connelly, D. J. Kelly, C. A. Pollock, and H. Krum Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 193 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Simons Angiogenesis, Arteriogenesis, and Diabetes: Paradigm Reassessed? J. Am. Coll. Cardiol., September 6, 2005; 46(5): 835 - 837. [Full Text] [PDF]
|
|
|
|
|
|
F. S. Villanueva Molecular Images of Neovascularization: Art for Art's Sake or Form With a Function? Circulation, June 21, 2005; 111(24): 3188 - 3191. [Full Text] [PDF]
|
|
|
|
|
|
G. P. Fadini, M. Miorin, M. Facco, S. Bonamico, I. Baesso, F. Grego, M. Menegolo, S. V. de Kreutzenberg, A. Tiengo, C. Agostini, et al. Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes Mellitus J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1449 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Simons Angiogenesis: Where Do We Stand Now? Circulation, March 29, 2005; 111(12): 1556 - 1566. [Full Text] [PDF]
|
|
|
|
|
|
J. Waltenberger Growth factor signal transduction defects in the cardiovascular system Cardiovasc Res, February 15, 2005; 65(3): 574 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Werner, E. Jandt, A. Krack, G. Schwarz, O. Mutschke, F. Kuethe, M. Ferrari, and H. R. Figulla Growth Factors in the Collateral Circulation of Chronic Total Coronary Occlusions: Relation to Duration of Occlusion and Collateral Function Circulation, October 5, 2004; 110(14): 1940 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Weihrauch, N. L. Lohr, B. Mraovic, L. M. Ludwig, W. M. Chilian, P. S. Pagel, D. C. Warltier, and J. R. Kersten Chronic Hyperglycemia Attenuates Coronary Collateral Development and Impairs Proliferative Properties of Myocardial Interstitial Fluid by Production of Angiostatin Circulation, May 18, 2004; 109(19): 2343 - 2348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Babiak, A.-M. Schumm, C. Wangler, M. Loukas, J. Wu, S. Dombrowski, C. Matuschek, J. Kotzerke, C. Dehio, and J. Waltenberger Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion Cardiovasc Res, March 1, 2004; 61(4): 789 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ouchi, H. Kobayashi, S. Kihara, M. Kumada, K. Sato, T. Inoue, T. Funahashi, and K. Walsh Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells J. Biol. Chem., January 9, 2004; 279(2): 1304 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J.M. Loomans, E. J.P. de Koning, F. J.T. Staal, M. B. Rookmaaker, C. Verseyden, H. C. de Boer, M. C. Verhaar, B. Braam, T. J. Rabelink, and A.-J. van Zonneveld Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes Diabetes, January 1, 2004; 53(1): 195 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Patel, L. Sun, D. Moshinsky, H. Chen, K. M. Leahy, P. Le, K. G. Moss, X. Wang, A. Rice, D. Tam, et al. A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular Permeability J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 838 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Y. Jiang, Z. He, B. L. King, T. Kuroki, D. M. Opland, K. Suzuma, I. Suzuma, K. Ueki, R. N. Kulkarni, C. R. Kahn, et al. Characterization of Multiple Signaling Pathways of Insulin in the Regulation of Vascular Endothelial Growth Factor Expression in Vascular Cells and Angiogenesis J. Biol. Chem., August 22, 2003; 278(34): 31964 - 31971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Koerselman, Y. van der Graaf, P. P.Th. de Jaegere, and D. E. Grobbee Coronary Collaterals: An Important and Underexposed Aspect of Coronary Artery Disease Circulation, May 20, 2003; 107(19): 2507 - 2511. [Full Text] [PDF]
|
|
|
|
|
|
O. Z. Lerman, R. D. Galiano, M. Armour, J. P. Levine, and G. C. Gurtner Cellular Dysfunction in the Diabetic Fibroblast: Impairment in Migration, Vascular Endothelial Growth Factor Production, and Response to Hypoxia Am. J. Pathol., January 1, 2003; 162(1): 303 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hirata, T.-S. Li, M. Nishida, H. Ito, M. Matsuzaki, S. Kasaoka, and K. Hamano Autologous bone marrow cell implantation as therapeutic angiogenesis for ischemic hindlimb in diabetic rat model Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H66 - H70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. M. Tepper, R. D. Galiano, J. M. Capla, C. Kalka, P. J. Gagne, G. R. Jacobowitz, J. P. Levine, and G. C. Gurtner Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures Circulation, November 26, 2002; 106(22): 2781 - 2786. [Abstract] [Full Text] [PDF]
|
|